venBio Global Strategic Fund, L.P.

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
venBio Global Strategic Fund, L.P.'s trades of Metacrine, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
127.85
Quantity 38,854 -10.7%
Value US$1,927,557
Transaction date
Sale
Price
60.90
Quantity 56,145 -32.8%
Value US$901,597
Transaction date
Purchase
Price
309.34
Quantity 62,521 +27.1%
Value US$1,610,933
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-10-26 2021-10-25
S Sale
38,854 -10.7%
127.85
US$1,927,557 		38,854 -10.7% 127.85 US$1,927,557
2021-10-26 2021-10-22
S Sale
56,145 -32.8%
60.90
US$901,597 		56,145 -32.8% 60.90 US$901,597
2020-09-22 2020-09-18
B Purchase
62,521 +27.1%
309.34
US$1,610,933 		62,521 +27.1% 309.34 US$1,610,933
2019-04-01 2019-04-01
B Purchase
50,000 +inf%
16.00
US$800,000 		50,000 +inf% 16.00 US$800,000